Podcasts about cjasn

On this ASN Kidney Translation Podcast, Dr. Matthew Sparks discusses key ADPKD studies: circadian clock disruption and cyst growth (JASN), depressive symptoms in adults with ADPKD (Kidney360), and biomarker-based kidney outcome prediction (CJASN).

In this episode of the ASN Kidney Translation Podcast series, Dr. Matthew Sparks dives into groundbreaking kidney stone research from JASN, CJASN, and Kidney360, exploring CKD risk, asymptomatic stone passage, and how pharmacotherapy affects recurrence.

CJASN Editor-in-Chief Rajnish Mehrotra interviews 2023 CJASN Trainee of the Year winner Rosa D. Wouda on her article, "Kaliuresis and Intracellular Uptake of Potassium with Potassium Citrate and Potassium Chloride Supplements."

CJASN Editor-in-Chief Rajnish Mehrotra interviews Tristan de Nattes, the 2023 CJASN Trainee of the Year second-place winner, on his article, "A Simple Molecular Tool for the Assessment of Kidney Transplant Biopsies."

CJASN Editor-in-Chief Rajnish Mehrotra interviews 2022 CJASN Trainee of the Year winner Bart J. Kramers on his article, "Effects of Hydrochlorothiazide and Metformin on Aquaresis and Nephroprotection by a Vasopressin V2 Receptor Antagonist in ADPKD."

CJASN Editor-in-Chief Rajnish Mehrotra interviews Insa Schmidt, the 2022 CJASN Trainee of the Year second-place winner, on her article, "Circulating Plasma Biomarkers in Biopsy-Confirmed Kidney Disease."

When we hear the word research, most of us think of innovative breakthrough treatments and technologies. But applied clinical research could not be possible without another type of research called basic science research in which scientists study the fundamental processes of the human body. In this episode, we'll learn what basic science research is and how it applies to the area of kidneys and kidney disease.   In this episode, we spoke with: Hannah Wesselman Hannah Wesselman is a PhD candidate at the University of Notre Dame studying the genetic mechanisms underlying kidney development in Dr. Rebecca Wingert's lab. Prior to her dissertation work, Hannah worked with Dr. Larissa Myaskovsky at the University of Pittsburgh Center for Research on Health Care, and their collaboration continued as Dr. Myaskovsky moved to the University of New Mexico Center for Healthcare Equity in Kidney Disease. During this time, Hannah worked directly with kidney transplant patients, and later published in CJASN on social determinants and race disparities in kidney transplant. Inspired by the strength of the kidney community, Hannah has returned to bench science in the hopes of identifying new treatment targets and has continued to connect with kidney patients through NKF advocacy. Holly Kramer, M.D., MPH Holly Kramer, M.D., MPH, is a practicing nephrologist who conducts research connecting nutrition and kidney health. Her connection to the National Kidney Foundation was inspired by her mom, who was a dialysis nurse and helped create some of the first dialysis units in Northwest Indiana. Dr. Kramer finds being on the NKF Board important, because it is the largest, patient-centered organization focusing on kidney disease. Her long-term goal is to increase national funding for kidney disease research and to heighten awareness about chronic kidney disease. Joseph V. Bonventre, M.D., PhD Dr. Bonventre is the Samuel A. Levine Distinguished Professor of Medicine and Constantine L. Hampers Distinguished Chair at Harvard Medical School and Professor of Health Sciences and Technology at the Massachusetts Institute of Technology. He is Chief of the Renal Division and Founding Chief of the Engineering in Medicine Division of the Brigham and Women's Hospital. In addition to his B.S. with distinction in Engineering Physics from Cornell, Dr. Bonventre holds M.D. and Ph.D. degrees in Biophysics from Harvard University.  He has honorary doctorate degrees from Mt. Saint Mary's College and from the Norwegian Institute of Science and Technology in Norway. He was Director of the Harvard-MIT Division of Health Sciences and Technology for 10 years.    Additional resources: Kidney Research NKF Research Connect NKF Patient Network Become an Advocate   Do you have comments, questions, or suggestions? Email us at NKFpodcast@kidney.org. Also, make sure to rate and review us wherever you listen to podcasts!

While FSGS was once thought to be a single disease entity, it is now understood to be a pattern of injury caused by diverse mechanisms, but classifying FSGS accurately can be challenging. In this episode, we provide an overview of these classifications and risk factors that can help stratify disease progression risk and assist with determining management approaches. To help understand how we can most effectively and accurately classify FSGS, we are joined by Professor An De Vriese, who is head of the Division of Nephrology and Infectious Disease at the AZ Sint-Jan hospital in Bruges, Belgium. By completing this activity you can qualify for 0.25 CME credits. To claim your credits, you must listen to the podcast and successfully pass the post-module assessment at nephrology.knowledgeintopractice.com, where you can find all past episodes of the podcast as well as other free CME resources. References: 1. De Vriese AS et al. Differentiating primary, genetic, and secondary FSGS in adults: A clinicopathologic approach. J Am Soc Nephrol 2018;29(3):759-774. 2. KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney Int 2021;100(4S):S1–S276. 3. Jacobs-Cachá C et al. Challenges in primary focal segmental glomerulosclerosis diagnosis: from the diagnostic algorithm to novel biomarkers. Clin Kidney J 2020;14(2):482-491. 4. Friedman DJ & Pollak MR. APOL1 nephropathy: From genetics to clinical applications. CJASN, 2021;16(2):294-303. 5. Zee J et al. APOL1 genotype-associated morphologic changes among patients with focal segmental glomerulosclerosis. Pediatric Nephrology. 2021;36(9):2747-2757. 6. Shabaka A et al. Focal segmental glomerulosclerosis: State-of-the-art and clinical perspective. Nephron 2020;144(9):413-427. Disclosures: Prof. An De Vriese has no disclosures to announce. Liberum IME staff, ACHL staff and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose. The Academy for Continued Healthcare Learning (ACHL) requires that the faculty participating in an accredited continuing education activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. All conflicts of interest have been mitigated prior to this activity. Funding: This independent educational activity is supported by an educational grant from Travere Therapeutics. The educational content has been developed by Liberum IME in conjunction with an independent steering committee; Travere Therapeutics has had no influence on the content of this education.

CJASN Editor-in-Chief Rajnish Mehrotra interviews Courtney Jane Lightfoot, the 2021 CJASN Trainee of the Year second-place winner, on the findings from her article, "Reliability and Validity of the Patient Activation Measure in Kidney Disease."

CJASN Editor-in-Chief Rajnish Mehrotra interviews Sook Hyeon Park, the 2021 CJASN Trainee of the Year first-place winner, on her article, "Combining Blood Gene Expression and Cellfree DNA to Diagnose Subclinical Rejection in Kidney Transplant Recipients."

著名肾脏病杂志CJASN发表了一项中位随访时间长达23年的研究发现：无糖饮料，会增加尿毒症风险！喝得越多，风险越大！

著名肾脏病杂志CJASN发表了一项中位随访时间长达23年的研究发现：无糖饮料，会增加尿毒症风险！喝得越多，风险越大！

著名肾脏病杂志CJASN发表了一项中位随访时间长达23年的研究发现：无糖饮料，会增加尿毒症风险！喝得越多，风险越大！

著名肾脏病杂志CJASN发表了一项中位随访时间长达23年的研究发现：无糖饮料，会增加尿毒症风险！喝得越多，风险越大！

Editor-in-Chief Rajnish Mehrotra interviews Karly Murphy on her article, "Association of Socioeconomic Status and Comorbidities with Racial Disparities during Kidney Transplant Evaluation," as well as her outlook on the field and advice for trainees.

Editor-in-Chief Rajnish Mehrotra interviews Jordan G. Nestor on her article, "Pilot Study of Return of Genetic Results to Patients in Adult Nephrology," as well as what sparked her interest in the field and where her research will take her.

Editor-in-Chief Rajnish Mehrotra interviews Karly Murphy on her article, "Association of Socioeconomic Status and Comorbidities with Racial Disparities during Kidney Transplant Evaluation," as well as her outlook on the field and advice for trainees.

Editor-in-Chief Rajnish Mehrotra interviews Jordan G. Nestor on her article, "Pilot Study of Return of Genetic Results to Patients in Adult Nephrology," as well as what sparked her interest in the field and where her research will take her.

The Filtrate:Joel TopfSwapnil HiremathSamira FaroukMatt SparksAnd special guests:Sadiya Kahn a heart failure specialist at Northwestern University. @HeartDocSadiyaandPaul Welling a professor of medicine and nephrology at Johns Hopkins. @PAWellingMDShow Notes:The Study: https://www.ahajournals.org/doi/abs/10.1161/CIRCULATIONAHA.120.045691Coverage at NephJC: http://www.nephjc.com/news/sglt2mechanismDiuretics for heart failure NEJM Review article: https://www.nejm.org/doi/full/10.1056/nejmra1703100Don’t say renal: https://www.kidney-international.org/article/S0085-2538(20)30233-7/fulltext?mobileUi=0Sanjiv “We pronounce HFpEF huff-puff” Shah, MD https://www.feinberg.northwestern.edu/faculty-profiles/az/profile.html?xid=16814 and https://asecho.org/wp-content/uploads/2016/02/Shah-HFpEF.pdfHuff Puff is like fetch. It is not going to happen. https://www.youtube.com/watch?v=Pubd-spHN-0Did he have buttons? https://ajkdblog.org/2019/06/17/muscle-relaxant-use-in-dialysis/Rate My Room: https://twitter.com/ratemyskyperoom?lang=enReview on Renal Glucosuria from CJASN: https://cjasn.asnjournals.org/content/5/1/133 and another from the National Organizations of Rare Disorders: https://rarediseases.org/rare-diseases/renal-glycosuria/Mechanism of Impaired Natriuretic Response to Furosemide during Prolonged Therapy: https://pubmed.ncbi.nlm.nih.gov/2811065/Two studies that showed drops in BNP with SGLT2iDAPA HF: https://www.nejm.org/doi/full/10.1056/NEJMoa1911303DEFINE HF showing nice reduction BNP with dapagliflozen: https://pubmed.ncbi.nlm.nih.gov/31524498/?dopt=AbstractCopeptin, what is it? https://pubmed.ncbi.nlm.nih.gov/18291667/?dopt=AbstractSIADH treatment with empagliflozen: https://jasn.asnjournals.org/content/31/3/615.abstract and it is JASN not CJASN. My bad.EVEREST. Tolvaptan for heart failure: https://jamanetwork.com/journals/jama/fullarticle/206251Remdesivir placebo controlled RCT: https://www.nejm.org/doi/full/10.1056/NEJMoa2007764Joel’s Remdesivir study: https://www.nejm.org/doi/full/10.1056/NEJMoa2007016Remdesivir for 5 or 10 Days in Patients with Severe Covid-19: https://www.nejm.org/doi/full/10.1056/NEJMoa2015301Swap showing a lot of skepticism to the Lancet HCQ data even before the retraction (which happened after this recording) https://www.the-scientist.com/news-opinion/lancet-retracts-surgispheres-study-on-hydroxychloroquine-67613Baclofen is dangerous https://www.kidney-international.org/article/S0085-2538(20)30552-4/abstract

This podcast by Dr. Jordan Nestor, on behalf of her colleagues, summarizes the article entitled, "Pilot Study of Return of Genetic Results to Patients in Adult Nephrology".

This podcast by Dr. Jordan Nestor, on behalf of her colleagues, summarizes the article entitled, "Pilot Study of Return of Genetic Results to Patients in Adult Nephrology".

Cast:Joel TopfSwapnil HiremathSamira FaroukJennie LinMatt SparksAnd special guest Joshua WaitzMartin Pollak: http://www.nasonline.org/member-directory/members/20033579.htmlJosh Waitz @jwaitz100 Days of COVID-19: https://www.voanews.com/episode/100-days-covid-19-4236811MinTac: http://www.nephjc.com/news/mintacMy magical experience with minimal change disease. This is not the actual tweet, but a dramatization: http://pbfluids.com/2020/04/the-magic-of-treating-minimal-change-disease/Non-inferiority, NephJC: http://www.nephjc.com/news/2019/7/8/understanding-the-vortex-of-non-inferiority-trialsNon-inferiority, through the looking glass: https://pubmed.ncbi.nlm.nih.gov/21539749/Kevin Fowler on Tacrolimus side effects: https://twitter.com/gratefull080504/status/1247697780736512000?s=20Mt Sinai is converting some transplant patients from tacrolimus to belatecept: https://www.nejm.org/doi/full/10.1056/nejmoa1506027CAPSULOLOGY: Open the “Images” tab https://www.webmd.com/drugs/2/drug-10097-6108/tacrolimus-oral/tacrolimus-oral/detailsTacrolimus for your cat and dog dry eye needs: https://vcahospitals.com/know-your-pet/tacrolimus-ophthalmic-in-dogsWHO, NSAIDs, and double negatives: https://twitter.com/kidney_boy/status/1240452941187821570?s=20CJASN stands for the Clinical Journal of the American Society of Nephrology. The C does not stand for Canada. Sorry Swap.Conversion calculator from old world (SI) units, mg/mole Cr, to freedom units (gram protein / gram creatinine): http://www.scymed.com/en/smnxps/psdjf223.htmMichelle Rheault about starting the clock to relapse tweet: https://twitter.com/rheault_m/status/1247703322200596483?s=20Marvin Gonzalez calls for larger studies: https://twitter.com/MarvinGonzlez16/status/1247701186972733442?s=20Acute PD for COVID-19 is discussed in this article from CJASN: https://cjasn.asnjournals.org/content/early/2020/04/03/CJN.03750320PD for AKI, the experience from Brazil https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525422/The lead author, Daniela Ponce is really the world authority on PD and AKI: https://www.ncbi.nlm.nih.gov/pubmed/?term=Ponce%20D%5BAuthor%5D&cauthor=true&cauthor_uid=22641732Nursing home outbreaks in Durham: https://www.newsobserver.com/news/coronavirus/article241975401.htmlPrison outbreak: https://www.npr.org/2020/04/06/827922287/inmates-staff-on-edge-as-covid-19-spreads-through-federal-prisonsOttawa COVID-19: https://ottawacitizen.com/news/local-news/covid-19-long-term-care-outbreaks-continue-devastating-spread-across-ontario/West Coast herd immunity: https://www.ksbw.com/article/new-study-investigates-californias-possible-herd-immunity-to-covid-19/32073873#The History of HIV associated Nephropathy: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494840/Racial breakdown of NYC coronavirus deaths reveals ‘disparities,’ de Blasio says https://nypost.com/2020/04/08/de-blasio-releases-racial-breakdown-data-of-coronavirus-deaths/Michelle Rheault is tired: https://twitter.com/rheault_m/status/1248371721356402689?s=20KidneyCon Lite! Saturday April 18 from 9-11. Kidney Pathology workshop.Lunch Doodles with Mo Willems: https://youtu.be/7KBkUyE6MOwDr Glaucomflecken and Telehealth: https://twitter.com/DGlaucomflecken/status/1247709538322657282?s=20NephSim for kindergartner’s https://nephsim.comNephSim live: https://twitter.com/Neph_SIM/status/1247637727048327170?s=20

Loeb’s Laws of Medicine or Loeb’s Rules of TherapeuticsRobert Frederick Loeb (March 14, 1895-October 21, 1973) was a famous American Physician who provided some very simple common sense approach to treating patients know as:1. If what you are doing is doing good, keep doing it.2. If what you are doing is not doing good, stop doing it.3. If you do not know what to do, do nothing.4. Never make the treatment worse than the disease.The last ‘law’ in present times is often replaced with:“If at all possible, keep your patient out of the operating room.”Or“Above all, never let a surgeon get your patient.”This is a decent reference for this: https://www.ncbi.nlm.nih.gov/books/NBK13258/Dr. Glaucomflecken gives some tips for attending trying to go back to the ICU: https://twitter.com/DGlaucomflecken/status/1238954558140772354?s=20Francis Deng and going back to become an internist: https://twitter.com/francisdeng/status/1245475268158009349?s=20JCI article on using convalescent serum for treating disease: https://www.jci.org/articles/view/138003Human trial of convalescent serum from JAMA: https://jamanetwork.com/journals/jama/fullarticle/2763983 It works! (in uncontrolled, observational trials)Monkeys develop protective antibodies: https://www.biorxiv.org/content/10.1101/2020.03.13.990226v1Time course for antibodies and viral clearance in SARS-CoV2 from Nature: https://www.nature.com/articles/s41586-020-2196-xPeripheral blood monocyte proeonomics: https://www.biorxiv.org/content/10.1101/2020.03.31.019216v1.full.pdfCytokine storm in the New York Times. Check mate Rheumatologists: https://www.nytimes.com/2020/04/01/health/coronavirus-cytokine-storm-immune-system.htmlDr. Anthony Chang and Thrombi on COVID biopsies: https://twitter.com/ChangUCanSpare/status/1240686922332160001?s=20ASN April 2 Webinar on dialysis and COVID-19 with Anitha Vijayan (among others): https://www.asn-online.org/ntds/resources/Webcast_2020_04_02_COVID-19.mp4UK data on length of ventilatory support (ICNARC): https://t.co/WB1ZnODRFF?amp=1Swap forgot Michele Mokrzycki’s name. Her name is Michele.Samira’s elementary school shampoo: https://www.influenster.com/reviews/pert-plus-classic-clean-2-in-1-shampoo-conditionerProlonged Intermittent Renal Replacement Therapy (PIRRT): https://www.ncbi.nlm.nih.gov/pubmed/27113696MDCalc COVID-Resource Center: https://www.mdcalc.com/covid-19Acute PD for COVID-19 is discussed in this article from CJASN: https://cjasn.asnjournals.org/content/early/2020/04/03/CJN.03750320PD for AKI, the experience from Brazil https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525422/The lead author, Daniela Ponce is really the world authority on PD and AKI: https://www.ncbi.nlm.nih.gov/pubmed/?term=Ponce%20D%5BAuthor%5D&cauthor=true&cauthor_uid=22641732NEJM ACE2 review article that Matt didn’t read or peer review: https://www.nejm.org/doi/full/10.1056/NEJMsr2005760NephJC COVID site: http://www.nephjc.com/covid19

Dr. Susan Shoaf summarizes the article entitled, "A Post Hoc Analysis of Statin Use in Tolvaptan Autosomal Dominant Polycystic Kidney Disease Pivotal Trials," on behalf of her co-authors.

Dr. Susan Shoaf summarizes the article entitled, "A Post Hoc Analysis of Statin Use in Tolvaptan Autosomal Dominant Polycystic Kidney Disease Pivotal Trials," on behalf of her co-authors.

This podcast is a summary by Dr. Suzanne Boyle and Dr. Karen Warburton on the study, "Nephrology Fellows' and Program Directors' Perceptions of Hospital Rounds in the United States" on behalf of their co-authors.

This podcast is a summary by Dr. Suzanne Boyle and Dr. Karen Warburton on the study, "Nephrology Fellows' and Program Directors' Perceptions of Hospital Rounds in the United States" on behalf of their co-authors.

Cast:Joel TopfJennie LinSwapnil HiremathMatt SparksShow Notes:NephJC Coverage of MENTOR: http://www.nephjc.com/news/mentorMENTOR: https://www.nejm.org/doi/full/10.1056/NEJMoa1814427KDIGO Membranous recommendations: https://kdigo.org/wp-content/uploads/2017/02/KDIGO-2012-GN-Guideline-English.pdf2017 Kidney Week Abstract: https://www.asn-online.org/education/kidneyweek/2017/program-abstract.aspx?controlId=2831149PEXIVAS: http://www.nephjc.com/news/pexivasearlyHeymann Nephritis: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3042693/Susan Quaggin: https://www.feinberg.northwestern.edu/faculty-profiles/az/profile.html?xid=26269Manasi Bapat on non-inferiority trials: http://www.nephjc.com/news/2019/7/8/understanding-the-vortex-of-non-inferiority-trialsPrognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan: https://www.sciencedirect.com/science/article/pii/S0085253815498503Nice review of Membranous by Alfaadhel and Cattrran that purports to say than CNI are the standard therapy for idiopathic membranous. (It doesn’t) https://www.ncbi.nlm.nih.gov/pubmed/27536673?dopt=AbstractPablo Garcia saves the day: https://twitter.com/PabloGarciaMD/status/1148767319323099136?s=20Larry beck’s land mark study demonstrating antiPLA2r as the antigen in idiopathic membranous. https://www.nejm.org/doi/full/10.1056/NEJMoa0810457GEMRITUX Study: https://www.ncbi.nlm.nih.gov/pubmed/27352623Jennie Lin’s How to Be a Nephrology Fellow, Choose Your Own Adventure: https://twitter.com/jenniejlin/status/1156329711057981442?s=20CJASN How to Review a Paper Podcast: https://www.asn-online.org/media/podcast/CJASN/2019_07_23_How_to_Write_a_Cons.mp3

This summary by Dr. Gianluigi Zaza, on behalf of his colleagues, discusses, "Proteomic Analysis of Urinary Microvesicles and Exosomes in Medullary Sponge Kidney Disease and Autosomal Dominant Polycystic Kidney Disease".

This summary by Dr. Gianluigi Zaza, on behalf of his colleagues, discusses, "Proteomic Analysis of Urinary Microvesicles and Exosomes in Medullary Sponge Kidney Disease and Autosomal Dominant Polycystic Kidney Disease".

Dr. Scott Weiss and colleagues discuss their recent article, "Major Adverse Kidney Events in Pediatric Sepsis".

Dr. Scott Weiss and colleagues discuss their recent article, "Major Adverse Kidney Events in Pediatric Sepsis".

Dr. Nazem Akoum summarizes "Rates of Cardiac Rhythm Abnormalities in Patients with Chronic Kidney Disease and Diabetes" on behalf of his colleagues.

Dr. Nazem Akoum summarizes "Rates of Cardiac Rhythm Abnormalities in Patients with Chronic Kidney Disease and Diabetes" on behalf of his colleagues.

Professor Jean-Michel Halimii summarizes the article entitled, "Etiologies and Outcomes of Thrombotic Microangiopathies" on behalf of his co-authors.

Professor Jean-Michel Halimii summarizes the article entitled, "Etiologies and Outcomes of Thrombotic Microangiopathies" on behalf of his co-authors.

In this podcast, Dr. Shuchi Anand discusses, the article entitled, "Prospective Biopsy-Based Study of Chronic Kidney Disease of Unknown Etiology in Sri Lanka" on behalf of her co-authors.

In this podcast, Dr. Shuchi Anand discusses, the article entitled, "Prospective Biopsy-Based Study of Chronic Kidney Disease of Unknown Etiology in Sri Lanka" on behalf of her co-authors.

In this podcast, Moumita Barua, MD summarizes the article, "Integration of Genetic Testing and Pathology for the Diagnosis of Adults with FSGS" on behalf of her co-authors.

In this podcast, Moumita Barua, MD summarizes the article, "Integration of Genetic Testing and Pathology for the Diagnosis of Adults with FSGS" on behalf of her co-authors.

In this podcast, Dr. Kevin Yau discusses his article, "Population-based Study of Risk of Acute Kidney Injury With Levetiracetam" on behalf of his co-authors.

In this podcast, Dr. Kevin Yau discusses his article, "Population-based Study of Risk of Acute Kidney Injury With Levetiracetam" on behalf of his co-authors.

On behalf of their co-authors, Charles Varnell and Hillarey Stone discuss their study entitled, Bleeding Complications after Pediatric Kidney Biopsy.

On behalf of their co-authors, Charles Varnell and Hillarey Stone discuss their study entitled, Bleeding Complications after Pediatric Kidney Biopsy.

On behalf of her co-authors, Dr. Virginia Wang summarizes their article entitled, "Medicare's New Prospective Payment System on Facility Provision of Peritoneal Dialysis".

On behalf of her co-authors, Dr. Virginia Wang summarizes their article entitled, "Medicare's New Prospective Payment System on Facility Provision of Peritoneal Dialysis".

Dr. Andrea Kattah summarizes, "CKD in Patients with Bilateral Oophorectomy" on behalf of her colleagues, in this podcast.

Dr. Andrea Kattah summarizes, "CKD in Patients with Bilateral Oophorectomy" on behalf of her colleagues, in this podcast.

Mr. Robert Ellis summarizes the article, "End-stage Kidney Disease Following Surgical Management of Kidney Cancer" on behalf of his co-authors.

Mr. Robert Ellis summarizes the article, "End-stage Kidney Disease Following Surgical Management of Kidney Cancer" on behalf of his co-authors.